Mosaic Immunoengineering Stock Fundamentals
| CPMV Stock | USD 1.00 0.01 1.01% |
Mosaic Immunoengineering fundamentals help investors to digest information that contributes to Mosaic Immunoengineerin's financial success or failures. It also enables traders to predict the movement of Mosaic OTC Stock. The fundamental analysis module provides a way to measure Mosaic Immunoengineerin's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mosaic Immunoengineerin otc stock.
Mosaic |
Mosaic Immunoengineering OTC Stock Shares Owned By Insiders Analysis
Mosaic Immunoengineerin's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Mosaic Immunoengineerin Shares Owned By Insiders | 88.73 % |
Most of Mosaic Immunoengineerin's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mosaic Immunoengineering is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 88% of Mosaic Immunoengineering are shares owned by insiders. This is much higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Mosaic Immunoengineering Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mosaic Immunoengineerin's current stock value. Our valuation model uses many indicators to compare Mosaic Immunoengineerin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mosaic Immunoengineerin competition to find correlations between indicators driving Mosaic Immunoengineerin's intrinsic value. More Info.Mosaic Immunoengineering is rated second in return on asset category among its peers. It is the top company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mosaic Immunoengineerin's earnings, one of the primary drivers of an investment's value.Mosaic Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mosaic Immunoengineerin's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mosaic Immunoengineerin could also be used in its relative valuation, which is a method of valuing Mosaic Immunoengineerin by comparing valuation metrics of similar companies.Mosaic Immunoengineerin is currently under evaluation in shares owned by insiders category among its peers.
Mosaic Fundamentals
| Return On Asset | -4.2 | |||
| Current Valuation | 10.22 M | |||
| Shares Outstanding | 7.24 M | |||
| Shares Owned By Insiders | 88.73 % | |||
| Price To Book | 9.33 X | |||
| EBITDA | (3.52 M) | |||
| Net Income | (3.68 M) | |||
| Cash And Equivalents | 205.99 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 735.15 K | |||
| Current Ratio | 0.07 X | |||
| Book Value Per Share | (0.60) X | |||
| Cash Flow From Operations | (679.24 K) | |||
| Earnings Per Share | (0.51) X | |||
| Beta | -1.79 | |||
| Market Capitalization | 6.01 M | |||
| Total Asset | 269.49 K | |||
| Z Score | -38.1 | |||
| Net Asset | 269.49 K |
About Mosaic Immunoengineerin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mosaic Immunoengineering's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mosaic Immunoengineerin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mosaic Immunoengineering based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. Mosaic Immunoengineerin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.